Biobotics

Biobotics is developing catalytic iron oxide nanoparticles and precision devices that safely eradicate biofilm-driven oral disease by replacing caustic irrigants and enhancing daily hygiene. The platform integrates into existing dental workflows and consumer products, enabling targeted antimicrobial activity, mechanical disruption, and scalable manufacturing. Initial products—a professional endodontic irrigant and catalytic toothbrush—target high-value U.S. professional and consumer markets while leveraging strategic B2B partnerships. Backed by extensive IP, peer-reviewed validation, and a multidisciplinary team from Penn, Biobotics aims to become the foundational technology provider for next-generation biofilm management across dentistry and broader healthcare.